نتایج جستجو برای: recombinant subunit vaccine

تعداد نتایج: 291266  

2014
Somayeh Kiaie Hamid Abtahi Ghasem Mosayebi MohammadYosef Alikhani Iraj Pakzad

BACKGROUND AND OBJECTIVES The toxin co-regulated pilus A (TcpA) has been described as a critical pathogenicity factor of Vibrio cholerae. TcpA is a candidate for making subunit vaccine against cholera. The aim of this study was to produce a candidate vaccine by expressing recombinant TcpA in E. coli. MATERIALS AND METHODS In this study, the toxin co-regulated pilus A gene from EL-Tor, V. chol...

ژورنال: پژوهش در پزشکی 2013
رجبی بذل, معصومه, رفیعی ده بیدی, غلامرضا, موسوی, سید لطیف, یغمایی, بهرام,

Abstract Background: Removal of prostate and radiotherapy are used routinely for treatment of prostate cancer however in advanced stages of the disease these treatments are ineffective. Researchers are exploring strategies for preventing this malignancy. This study aims to design and develop a phage based vaccine for preventing prostate cancer. Materials and methods: After conducting bioinforma...

2015
Kathleen A Ross Hyelee Loyd Wuwei Wu Lucas Huntimer Shaheen Ahmed Anthony Sambol Scott Broderick Zachary Flickinger Krishna Rajan Tatiana Bronich Surya Mallapragada Michael J Wannemuehler Susan Carpenter Balaji Narasimhan

H5N1 avian influenza is a significant global concern with the potential to become the next pandemic threat. Recombinant subunit vaccines are an attractive alternative for pandemic vaccines compared to traditional vaccine technologies. In particular, polyanhydride nanoparticles encapsulating subunit proteins have been shown to enhance humoral and cell-mediated immunity and provide protection upo...

Amir Ghasemi, Jafar Amani, Mahdi Shabani Mahdi Zandemami Reza Golmohammadi, Reza Ranjbar,

Objective(s): Brucella spp. are facultative intracellular pathogens which can stay alive and multiply in professional and nonprofessional phagocytes. Immunity against Brucella melitensis involves antigen-specific CD4+ and CD8+ T-cells activation and humoral immune responses. Due to negative aspects of live attenuated vaccines, much attention has been focused on finding Brucella-protective antig...

2010
Tze-Hoong Chua Connie Y. H. Leung H. E. Fang Chun-Kin Chow Siu-Kit Ma Sin-Fun Sia Iris H. Y. Ng Stanley G. Fenwick Cassandra M. James Sin Bin Chua Siang Thai Chew Jimmy Kwang J. S. M. Peiris Trevor M. Ellis

The protective efficacy of a subunit avian influenza virus H5 vaccine based on recombinant baculovirus expressed H5 haemagglutinin antigen and an inactivated H5N2 avian influenza vaccine combined with a marker antigen (tetanus toxoid) was compared with commercially available inactivated H5N2 avian influenza vaccine in young ducks. Antibody responses, morbidity, mortality, and virus shedding wer...

Journal: :Acta biochimica Polonica 2014
Patrycja Redkiewicz Agnieszka Sirko Katarzyna Anna Kamel Anna Góra-Sochacka

Many examples of a successful application of plant-based expression systems for production of biologically active recombinant proteins exist in the literature. These systems can function as inexpensive platforms for the large scale production of recombinant pharmaceuticals or subunit vaccines. Hemagglutinin (HA) is a major surface antigen of the influenza virus, thus it is in the centre of inte...

Background and purpose: The sequence of Omp25 is conserved in all Brucella species. The high antigenicity of the product of this gene stimulates the host’s immune system. Using engineered probiotic bacteria is an appropriate method for vaccine transport. The aim of this study was to express the Omp25 of the Brucella abortus pathogenic bacterium in Lactococcus lactis probiotic bacterium. Materi...

Journal: :Vaccine 2010
Faust René Okamba Maximilien Arella Nedzad Music Jian Jun Jia Marcelo Gottschalk Carl A Gagnon

Mycoplasma hyopneumoniae causes severe economic losses to the swine industry worldwide and the prevention of its related disease, enzootic porcine pneumonia, remains a challenge. The P97 adhesin protein of M. hyopneumoniae should be a good candidate for the development of a subunit vaccine because antibodies produced against P97 could prevent the adhesion of the pathogen to the respiratory epit...

Journal: :The Journal of experimental biology 2003
Thomas C Luke Stephen L Hoffman

Annually, malaria causes >300 million clinical cases and 1 million deaths, is responsible for the loss of >1% of gross domestic product (GDP) in Africa and is a serious concern for travelers. An effective vaccine could have a dramatic impact on the disease. For 20 years, scientists have tried to develop modern, recombinant 'subunit' malaria vaccines. This has been difficult. In fact, there is o...

Journal: :European Medical Journal Neurology 2023

While people with multiple sclerosis (MS) are not more likely to contract COVID-19, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19-related complications may be higher for MS who have comorbidities or taking certain disease modifying therapies (DMT). Robert Shin, Professor Neurology at MedStar Georgetown University Hospital, Washington, D.C....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید